official

Evidence page

Takeda Update on Alofisel (darvadstrocel)

Takeda Pharmaceutical Company

Published Dec 13, 2024accessed Sep 18, 2026Updated Sep 19, 2026

Original source

https://www.takeda.com/newsroom/statements/2024/takeda-alofisel-update-2024/

takeda.com

Verification

Verification	Not yet verified
Evidence level	—
Source	official
Link status	Reachable at last check

Official claims are statements by the provider; they are not verified by worldwiki unless marked otherwise. Source policy

Cited by (1)

FactAdipose-derived Stem Cell: Phase 3 confirmatory trial result (ADMIRE-CD II) (official claim) = 568 patients; primary endpoint (combined remission at 24 weeks) not met; no statistical difference in secondary endpoints patients